Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer
NCT ID: NCT06495346
Last Updated: 2024-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2023-12-11
2025-06-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This decision tree should help to improve the management of patients with a cancer diagnosis presenting with sleep disorders.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Disturbance in Lung Cancer Patients.
NCT00187980
Sleep State in Lung Cancer: A Retrospective Analysis
NCT06953492
Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
NCT02648087
Sleep Disorders in Patients With Suspected Lung Cancer Before and After Thoracic Surgery
NCT04759651
Sleep Disorders and Tumor Immune Microenvironment
NCT06941948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
self-questionnaires exploring
At each stage, subjects are asked to fill in self-questionnaires exploring the quality of their sleep, their potential distressing symptoms, their psychological state and the quality of their life at that moment. They complete the self-questionnaires at t
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being monitored and treated for non-small cell lung cancer.
* With or without ongoing cancer-specific treatment. With no neurocognitive impairment (MoCA test score ≥26/30).
* With a clinically assessed life expectancy of more than 3 months (Royal Marsden Hospital 0-1) and general health (ECOG \<2).
* Able to understand the study documents written in French
* Able to complete the study questionnaires written in French.
* Contactable by telephone throughout the study
* Affiliated to a social security scheme or entitled beneficiary
* Not opposed to taking part in the study
Exclusion Criteria
* With a mental illness of the psychosis type monitored and treated prior to the study
* Patient under guardianship or curatorship
* Patient under court protection
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HUS
Strasbourg, Grand Est, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.